目錄:杭州斯達特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B0566Anti-PD-1 Monoclonal Antibody(Nivolumab)
Nivolumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells.
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)